Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
CA 2485081 C · Owner: Feldman, David Louis · Inventors: Webb, Randy Lee; Feldman, David Louis
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to a pharmaceutical composition comprising (i) a renin inhibitor, (ii) a calcium channel blocker (CCB) and (iii) a diuretic and to a , method of treatment of a condition or a disease selected from the group consisting of hypertension, heart failure such as (acute and chronic) congestive heart failure, left ventricular dysfunction and hypertrophic cardiomyopathy, diabetic cardiac myopathy supraventricular and ventricular , arrhythmias atrial fibrillation, atrial flutter, detrimental vascular remodeling, myocardial infarction and its sequelae atherosclerosis, angina , (whether unstable or stable) renal insufficiency (diabetic and non- diabetic), heart failure, …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 16, 2003 and granted January 8, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 16, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 16, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.